Handa, Yoshinori <br/><br/>
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.  [electronic resource] 

 -  Clinical lung cancer  07 2020 
 - e302-e314 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1938-0690 
<br/><br/><label>Standard No.: </label>10.1016/j.cllc.2020.01.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma of Lung--immunology<br/>Aged<br/>B7-H1 Antigen--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--immunology<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--immunology<br/>Neoplasm Staging<br/>Programmed Cell Death 1 Receptor--immunology<br/>Retrospective Studies<br/>Survival Rate<br/>Tumor Microenvironment--immunology